Premier Alternatives

DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.

PMV mark · valuation
$659.7M
Oct 2026
Priced at
its later-stage round
Jan 2022
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022

DNA Script key facts

as of Oct 2026
  • Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications.
  • DNA Script is valued at approximately $659.7M as of Oct 2026, set at its later-stage round, Jan 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $298.7M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($191.7M) in Jan 2022.
  • Notable investors include Bpifrance, Fidelity Management & Research Company, European Commission, Coatue Management, La French Tech — 34 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$659.7M

Valued at $659.7M at its later-stage round, Jan 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of DNA Script with a free account
  • ·The complete investor list: 34 names
  • ·Watch DNA Script: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

DNA Script funding rounds

1 rounds
Jan 2022Later Stage VC (Series C)$191.7M▮
Full funding history →

DNA Script valuation

DNA Script was valued at $660 million at its later-stage round in Jan 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DNA Script raised?

DNA Script has raised $299 million in total; 1 of its rounds is on record. The largest on record was a $192 million Series C in Jan 2022.

DNA Script investors

34 investors are on record for DNA Script, including Bpifrance, Fidelity Management & Research Company, European Commission and Coatue Management. By type, the record holds 8 venture capital firms and 4 hedge funds. The Series C in Jan 2022 drew 20 investors.

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: Cardurion ($760 million), Odyssey Therapeutics ($638 million) and bit.bio ($546 million).

About DNA Script

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. The company's technology features a novel biochemical process for nucleic acid synthesis based on the use of efficient enzymes to provide rapid production of important genomic experimental precursors, such as an oligonucleotide, enabling researchers to accelerate their experiments and development of new therapeutics.

Industry
Biotechnology
Sector
Healthcare
HQ
Paris, France
Founded
2014
Employees
142
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.